Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.13 NZD 5.69% Market Closed
Market Cap: 105.5m NZD
Have any thoughts about
Pacific Edge Ltd?
Write Note
PEB
/
Cash Flow Statement
/
Net Change in Cash

Pacific Edge Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pacific Edge Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Pacific Edge Ltd
NZX:PEB
Net Change in Cash
-NZ$4m
CAGR 3-Years
N/A
CAGR 5-Years
-59%
CAGR 10-Years
-10%
Aroa Biosurgery Ltd
ASX:ARX
Net Change in Cash
NZ$2m
CAGR 3-Years
-44%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Pacific Edge Ltd
Glance View

Market Cap
105.5m NZD
Industry
Biotechnology

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The firm develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The firm's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and operation of the laboratories used for the detection of bladder cancer in the United States and New Zealand. The company offers Cxbladder, which is a suite of non-invasive laboratory tests for the detection and the management of bladder cancer. Cxbladder includes a suite of urine-based molecular tests to determine the likelihood of bladder cancer in patients presenting with hematuria. Its pipeline includes Cxcolorectal, which is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer, enabling prediction of aggressiveness of the tumor.

PEB Intrinsic Value
0.55 NZD
Undervaluation 77%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Pacific Edge Ltd's Net Change in Cash?
Net Change in Cash
-4m NZD

Based on the financial report for Mar 31, 2024, Pacific Edge Ltd's Net Change in Cash amounts to -4m NZD.

What is Pacific Edge Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-10%

Over the last year, the Net Change in Cash growth was -82%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.